The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Waning efficacy of COVID-19 vaccination at six months in patients (pts) with genitourinary malignancies.
 
Zeynep Busra Zengin
No Relationships to Disclose
 
Luis A Meza
No Relationships to Disclose
 
Jasnoor Malhotra
No Relationships to Disclose
 
Sabrina Salgia
No Relationships to Disclose
 
Jennifer Ely
No Relationships to Disclose
 
Joann Hsu
No Relationships to Disclose
 
Erin Kelley
No Relationships to Disclose
 
Heather Mead
No Relationships to Disclose
 
Nazli Dizman
Consulting or Advisory Role - Vivreon Biosciences
 
Alex Chehrazi-Raffle
No Relationships to Disclose
 
Ameish Govindarajan
No Relationships to Disclose
 
Ramya Muddasani
Stock and Other Ownership Interests - Abbvie; Abbvie; Actinium Pharmaceuticals; Actinium Pharmaceuticals (I); Advaxis (I); Agenus; Agenus (I); Aprea Therapeutics; Aprea Therapeutics (I); Athenex (I); AVEO (I); Cellectar; Cellectar (I); crispr therapeutics (I); Curis (I); DelMar Pharmaceuticals; DelMar Pharmaceuticals (I); DelMar Pharmaceuticals (I); Epizyme; Epizyme (I); Forty Seven; Forty Seven (I); Gritstone Bio (I); Heat Biologics (I); Immunomedics; Immunomedics (I); Mereo BioPharma (I); NantHealth (I); NantKwest,; NantKwest, (I); Novavax (I); Onconova Therapeutics; Onconova Therapeutics (I); Pfizer (I); Portola Pharmaceuticals (I); Vaxart
 
Neal Shiv Chawla
No Relationships to Disclose
 
Tanya B. Dorff
Consulting or Advisory Role - Abbvie; Advanced Accelerator Applications; Bayer; Bristol-Myers Squibb; Dendreon; Exelixis; Janssen Oncology; Noxopharm; Seagen
Research Funding - Pfizer (Inst)
 
Yung Lyou
Consulting or Advisory Role - Pfizer/EMD Serono; Seattle Genetics/Astellas
Speakers' Bureau - Janssen Oncology
 
Ewa Karczewska
No Relationships to Disclose
 
Jeffrey M. Trent
No Relationships to Disclose
 
Ravi Salgia
Consulting or Advisory Role - Abbvie; AstraZeneca; Iovance Biotherapeutics; Novartis
Speakers' Bureau - AstraZeneca; Merck
 
John Altin
No Relationships to Disclose
 
Sumanta K. Pal
Consulting or Advisory Role - F. Hoffmann LaRoche; F. Hoffmann LaRoche; Roche
Research Funding - Eisai (Inst); Exelixis (Inst); Genentech (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Genentech; Seagen